Link to this page
Biological and Environmental Research Ontology
| Id | http://purl.obolibrary.org/obo/NCIT_C103865
http://purl.obolibrary.org/obo/NCIT_C103865
|
|---|---|
| Preferred Name | Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001 |
| Definitions |
A cell-based product containing autologous bone marrow derived CD34 positive and C-X-C chemokine receptor type 4 (CXCR4) positive stem cells with potential antiapoptotic and proangiogenic activities. Upon intracoronary infusion after a myocardial infarction (MI), autologous bone marrow-derived CD34/CXCR4-positive stem cells may preserve cardiac muscle cells and prevent apoptosis; thus improving myocardial perfusion. CD34/CXCR4-positive stem cells are naturally mobilized upon cell injury through signaling by hypoxia inducing factor (HIF), which is secreted in response to hypoxia. In turn, HIF induces the synthesis of stromal-derived factor 1 (SDF-1) and vascular endothelial growth factor (VEGF) which mobilize CD34/CXCR4 positive stem cells; CXCR4 is the receptor for stromal-derived factor 1 (SDF-1).
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A cell-based product containing autologous bone marrow derived CD34 positive and C-X-C chemokine receptor type 4 (CXCR4) positive stem cells with potential antiapoptotic and proangiogenic activities. Upon intracoronary infusion after a myocardial infarction (MI), autologous bone marrow-derived CD34/CXCR4-positive stem cells may preserve cardiac muscle cells and prevent apoptosis; thus improving myocardial perfusion. CD34/CXCR4-positive stem cells are naturally mobilized upon cell injury through signaling by hypoxia inducing factor (HIF), which is secreted in response to hypoxia. In turn, HIF induces the synthesis of stromal-derived factor 1 (SDF-1) and vascular endothelial growth factor (VEGF) which mobilize CD34/CXCR4 positive stem cells; CXCR4 is the receptor for stromal-derived factor 1 (SDF-1). |
|---|---|
| prefLabel | Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001
|
| label | Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001
|
| NCI_META_CUI | CL438343
|
| PDQ_Closed_Trial_Search_ID | 743421
|
| code | C103865
|
| prefixIRI | NCIT:C103865
|
| in_subset |
See more
See less
|
| Display_Name | Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001
|
| Preferred_Name | Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001
|
| Contributing_Source | CTRP
|
| Maps_To | Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001
|
| NCI_Drug_Dictionary_ID | 743421
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 743421
|
| Semantic_Type | Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |